Diagnosis and treatment of diabetic foot infections

Bailliere's Best Practice and Research in Clinical Rheumatology

Volumn 13, Issue 1, 1999, Pages 149-161

  Tan, James S ^a,b   File Jr , Thomas M ^a,b  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

Author keywords

Diabetes; Foot infection

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; BONE BIOPSY; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC FOOT; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HUMAN; LENGTH OF STAY; MOBILIZATION; OSTEOMYELITIS; PRIORITY JOURNAL; REVIEW; TISSUE CULTURE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DIABETIC FOOT; HUMANS;

EID: 0041778762     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.1999.0011     Document Type: Article

References (62)

1. Apelqvist J, Ragnarson-Tennvall G, Larsson J & Persson U (1995) Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot and Ankle 16: 388-394.
2. Apelqvist J, Ragnarson-Tennvall G, Persson U et al (1994) Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputation. Journal of Internal Medicine 235: 463-471.
3. Armstrong DG, Lavery LA, Vela SA et al (1998) Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Archives of Internal Medicine 158: 289-292.
4. Bailey TS, Yu HM & Ratfield E (1985) Patterns of foot examination in a diabetic clinic. American Journal of Medicine 78: 371-374.
5. * Bamberger DM, Daus GP & Gerding DN (1987) Osteomyelitis in the feet of diabetic patients: long-term results, prognostic factors, and the role of antimicrobial and surgical therapy. American Journal of Medicine 83: 653-660.
6. Benton GS & Kerstein MD (1985) Cost-effectiveness of early digit amputation in the patient with diabetes. Surgery, Gynecology and Obstetrics 161: 523-524.
7. Blume PA, Dey HM, Daley LJ et al (1997) Diagnosis of pedal osteomyelitis with Tc99m HMPAQ labeled leukocytes. Journal of Foot and Ankle Surgery 36: 120-126.
8. Bose K (1979) A surgical approach for the infected diabetic foot. International Orthopaedics 3: 177-181.
9. Bridges MRJ (1994) Diabetic foot infections. Surgical Clinics of North America 74: 537-555.
10. Calandra GB, Raupp W & Brown KR (1987) Imipenem/cilastatin treatment of lower extremity skin and soft tissue infections in diabetics. Scandinavian Journal of Infectious Disease 52 (supplement): 15-19.
11. * Caputo GM, Cavanagh PR, Ulbrecht JS et al (1994) Assessment and management of foot disease in patients with diabetes. New England Journal of Medicine 331: 854-860.
12. Center for Disease Control (1991) Lower extremity amputations among persons with diabetes mellitus-Washington 1988. Morbidity and Mortality Weekly Review 40: 737-739.
13. Cook TA, Rahim N, Simpson HC & Galland RB (1996) Magnetic resonance imaging in the management of diabetic foot infection. British Journal of Surgery 83: 245-248.
14. Crerand S, Dolan M, Laing P et al (1996) Diagnosis of osteomyelitis in neuropathic foot ulcers. Journal of Bone and Joint Surgery 78B: 51-55.
15. Croll SD, Nicholas GG, Osborne MA et al (1996) Role of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. Journal of Vascular Surgery 24: 266-270.
16. * Eckman MH, Greenfield S, Mackey WC et al (1995) Foot infections in diabetic patients. Decision and cost-effectiveness analyses. Journal of the American Medical Association 273: 712-720.
17. Edelson GW, Armstrong DG, Lavery LA & Caicco G (1996) The acutely infected diabetic foot is not adequately evaluated on an inpatient setting. Archives of Internal Medicine 156: 2373-2378.
18. Edmonds ME, Blundell MP, Morris HE et al (1986) The diabetic foot: impact of a foot clinic. Quarterly Journal of Medicine 232: 763-771.
19. File TM & Tan JS (1983) Amdinocillin plus cefoxitin versus cefoxitin alone in therapy of mixed soft tissue infections (including diabetic foot infections). American Journal of Medicine 74 (supplement): 100-105.
20. File TMJ & Tan JS (1991) Ticarcillin-clavulanate therapy for bacterial skin and soft tissue infections. Review of Infectious Diseases 13 (supplement 9): S733-S736.
21. Gerding DN (1995) Foot infections in diabetic patients: the role of anaerobes. Clinical Infectious Diseases 20 (supplement 2): S283-S288.
22. Giacalone VF, Krych SM & Harkless LB (1994) The University of Texas Health Science Center at San Antonio: experience with foot surgery in diabetics. Journal of Foot and Ankle Surgery 33: 590-597.
23. Gibbons GW (1987) The diabetic foot: amputations and drainage of infection. Journal of Vascular Surgery 5: 791-793.
24. Goldner MG (1960) The fate of the second leg in the diabetic amputee. Diabetes 9: 100-103.
25. * Grayson ML (1995) Diabetic foot infections. Antimicrobial therapy. Infectious Disease Clinics of North America 9: 143-161.
26. Grayson ML, Gibbons GW, Habershaw GM et al (1994) Use of ampicillin/sulbactam versus imipenem/ cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clinical Infectious Diseases 18: 683-693.
27. Grayson ML, Gibbons GW, Balogh K et al (1995) Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. Journal of the American Medical Association 273: 721-723.
28. Hughes CE, Johnson CC, Bamberger CM et al (1987) Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime. Clinical Therapeutics 10 (supplement): 36-49.
29. Humphrey LL, Palumbo PJ, Butters MA et al (1994) The contribution of non-insulin-dependent diabetes to lower-extremity amputation in the community. Archives of Internal Medicine 154: 885-892.
30. Johnson CC, Reinhardt JF, Wallace SL et al (1985) Safety and efficacy of ticarcillin plus clavulanic acid in the treatment of soft tissue, bone and joint. American Journal of Medicine 79 (supplement 5B): 136-140.
31. Joseph WS (1991) Treatment of lower extremity infections in diabetics. Drugs 42: 984-996.
32. Keenan AM, Tindel NL & Alavi A (1989) Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Archives of Internal Medicine 149: 2262-2266.
33. Lavery LA, Armstrong DG, Vela SA et al (1998) Practical criteria for screening patients at high risk for diabetic foot ulceration. Archives of Internal Medicine 158: 158-162.
34. LeFrock JL, Johnson ES, Smith LG & Rosenberg E (1985) Noncomparative trial of ticarcillin plus clavulanic acid in skin and soft tissue infections. American Journal of Medicine 79 (supplement 5B): 122-125.
35. Levin ME (1991) Pathophysiology of diabetic foot lesions. In Davidson JK (ed.) Clinical Diabetes Mellitus, pp 504-520. New York: Theime Medical.
36. Liedberg E & Persson B (1983) Age, diabetes and smoking in lower limb amputation for arterial occlusive disease. Acta Orthopedica Scandinavica 54: 383-388.
37. * Lipman BT, Collier BD, Carrera GF et al (1998) Detection of osteomyelitis in the neuropathic foot: nuclear medicine, MRI and conventional radiography. Clinical and Nuclear Medicine 23: 77-82.
38. * Lipsky BA (1997) Osteomyelitis of the foot in diabetic patients. Clinical Infectious Diseases 25: 1318-1326.
39. Lipsky B, Pecoraro R, Larson S et al (1990) Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Archives of Internal Medicine 150: 790-797.
40. Meade JW (1968) Major infections of the foot. Medical Times 96: 154-169.
41. Most RS & Sinnock P (1983) The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 6: 87-91.
42. Nix DE, Cumbo TJ, Kuritzky P et al (1987) Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. American Journal of Medicine 82 (supplement 4A): 146-153.
43. Ogbuawa O, Williams J & Henry W Jr (1982) Diabetic gangrene in black patients. Southern Medical Journal 75: 285-288.
44. Pecoraro R, Reiber G & Burgess E (1990) Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 13: 513-521.
45. Peterson LR, Lisack LM, Canter K et al (1989) Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. American Journal of Medicine 86: 801-808.
46. Pliskin MA, Todd WF & Edelson GW (1994) Presentations of diabetic feet. Archives of Family Medicine 3: 273-279.
47. Roon AJ, Moore WS & Goldstone J (1977) Below knee amputation: a modern approach. American Journal of Surgery 134: 153-158.
48. Rosenblum BI, Pomposelli FBJ, Giurini JM et al (1994) Maximizing foot salvage by a combined approach to foot ischemia and neuropathic ulceration in patients with diabetes. Diabetes Care 17: 983-987.
49. Sapico FL, Bessman AN & Canawati HN (1982) Bacteremia in diabetic patients with infected lower extremities. Diabetes Care 5: 101-104.
50. * Sapico FL, Canawati HN, Witte JL et al (1980) Quantitative aerobic and anaerobic bacteriology of the infected diabetic foot. Journal of Clinical Microbiology 12: 413-420.
51. Siebert WT & Kopp PE (1985) Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis and skin and soft tissue infections. American Journal of Medicine 79 (supplement 5B): 141-143.
52. Steed DL, Donohoe D, Webster MW & Lindsley L (1996) Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Journal of the American College of Surgeons 183: 61-64.
53. Tan JS, File TMJ & Salstrom S-J (1985) Timentin versus moxalactam in the treatment of skin and soft tissue infections. American Journal of Medicine 79 (supplement 5B): 130-133.
54. Tan JS, Flanagan PJ, Donovan DL & File TM (1987) Team approach in the management of diabetic foot infections. Journal of Foot Surgery 26 (supplement 1): S12-S16.
55. Tan JS, Wishnow RM, Talan DA et al (1993) Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-azobactam versus ticarcillin-clavulanate. Antimicrobial Agents and Chemotherapy 37: 1580-1586.
56. * Tan JS, Friedman NM, Hazelton-Miller C et al (1996) Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation? Clinical Infectious Diseases 23: 286-291.
57. Tassler H, Cullmann W & Elhardt D (1993) Therapy of soft tissue infections with piperacillin/tazobactam. Journal of Antimicrobial Chemotherapy 31 (supplement A): 105-112.
58. Todd WF, Armstrong DG & Liswood PJ (1996) Evaluation and treatment of the infected foot in a community teaching hospital. Journal of the American Podiatric Medical Association 86: 421-426.
59. Van GH, Sachon C, Siney H et al (1996) Treatment of osteomyelitis in the diabetic foot. Diabetes Care 19: 1257-1260.
60. Wheat LJ (1980) Infection and diabetes mellitus. Diabetes Care 3: 187-197.
61. * Wheat JL, Allen SD & Henry M (1986) Diabetic foot infections: bacteriologic analysis. Archives of Internal Medicine 146: 1935-1940.
62. Wylie-Tosset J, Walker EA, Shamoon H et al (1995) Assessment of documented foot examinations for patients with diabetes in inner city primary care clinics. Archives of Family Medicine 4: 46-50.